Synopsis Clinical evidence suggests that novel ambulatory Syncope Assessment Unit (SAU) promotes early discharge from hospital with prompt outpatient medical review and shorter inpatient waiting times for diagnostic investigations. The present study aims to evaluate the safety and cost-effectiveness of Syncope Assessment Unit (SAU) in managing low-risk syncope patients. This week’s “ MED FACT ” discusses a clinical study from The British Journal of Cardiology, “ A novel ambulatory syncope assessment unit is safe and cost-effective in a low-risk patient cohort ”.
April 2018. Authors : Hamish I MacLachlan; Christopher J Allen; Gothandaraman Balaji; et al. Key Takeaways: SAU helps in early discharge from hospital and shorter inpatient waiting times for diagnostic investigations Objective: To evaluate the safety and cost-effectiveness of Syncope Assessment Unit (SAU) in low-risk syncope…
